University of Ljubljana School of Medicine, Slovenia
19
3
3
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.5% vs industry average
11%
2 trials in Phase 3/4
30%
3 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Different Amoxicillin Treatment Regimens in Erythema Migrans Patients
Role: collaborator
CTNNB1 Neurodevelopmental Syndrome - Natural History Study
Role: collaborator
Tick-borne Encephalitis and Borrelial Antibodies in Serum
Role: collaborator
Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting
Role: collaborator
Inflammatory Mediators in Erythema Migrans
Role: collaborator
Duration of Doxycycline Treatment in EM Patients
Role: collaborator
Inflammatory Responses in Solitary and Multiple Erythema Migrans
Role: collaborator
Tick-borne Encephalitis and Possible Borrelial Serology
Role: collaborator
Cytokines and Chemokines in Erythema Migrans
Role: collaborator
Tick-borne Encephalitis and Positive Borrelial Antibodies
Role: collaborator
Aseptic Meningoencephalitis in Slovenia
Role: collaborator
Laboratory Characteristics in Chronic Atrophic Acrodermatitis
Role: collaborator
Buccal Plate Augmentation With Different Hydroxyapatite Based Material
Role: collaborator
Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely
Role: collaborator
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
Role: collaborator
Culture Media for Borrelia Burgdorferi Sensu Lato
Role: collaborator
E-health Care Process Support for Diabetes Type II Patients
Role: collaborator
Respiratory Viral Infection in Nursing Home Slovenia
Role: collaborator
Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age
Role: collaborator
All 19 trials loaded